All
FDA Approves First Targeted Therapy to Treat Metastatic Bladder Cancer
April 12th 2019The Food and Drug Administration granted accelerated approval to Balversa to treat locally advanced or metastatic bladder cancer with a type of susceptible genetic alterations known as FGFR3 or FGFR2, in patients who have progressed during or following prior platinum-containing chemotherapy.
PTSD and the Felt Reality of Living with Chronic Disease
April 11th 2019For those of us living in the wake of a big diagnosis, how we define life, living and every day can be clouded by fear and misguided ideas of what it means to truly live. What I’ve learned is that life is not about what we are doing, but why and how we do what we have to for however long we get to be alive.